Dr Reddy's Laboratories Property, Plant, and Equipment 2010-2024 | RDY

Dr Reddy's Laboratories property, plant, and equipment from 2010 to 2024. Property, plant, and equipment can be defined as the sum of all net property, plant & Equipment fields. Where companies do not report a break down of plant, property, & equipment, the value is entered in this field alone.
  • Dr Reddy's Laboratories property, plant, and equipment for the quarter ending June 30, 2024 was $0.964B, a 17.7% increase year-over-year.
  • Dr Reddy's Laboratories property, plant, and equipment for 2024 was $0.923B, a 14.09% increase from 2023.
  • Dr Reddy's Laboratories property, plant, and equipment for 2023 was $0.809B, a 1.22% decline from 2022.
  • Dr Reddy's Laboratories property, plant, and equipment for 2022 was $0.819B, a 4.87% increase from 2021.
Dr Reddy's Laboratories Annual Property, Plant, and Equipment
(Millions of US $)
2024 $923
2023 $809
2022 $819
2021 $781
2020 $694
2019 $782
2018 $889
2017 $881
2016 $815
2015 $772
2014 $740
2013 $694
2012 $653
2011 $666
2010 $500
2009 $
Dr Reddy's Laboratories Quarterly Property, Plant, and Equipment
(Millions of US $)
2024-06-30 $964
2024-03-31 $923
2023-12-31 $875
2023-09-30 $848
2023-06-30 $819
2023-03-31 $809
2022-12-31 $786
2022-09-30 $784
2022-06-30 $808
2022-03-31 $819
2021-12-31 $846
2021-09-30 $813
2021-06-30 $789
2021-03-31 $781
2020-12-31 $771
2020-09-30 $748
2020-06-30 $712
2020-03-31 $694
2019-12-31 $739
2019-09-30 $750
2019-06-30 $785
2019-03-31 $782
2018-12-31 $795
2018-09-30 $781
2018-06-30 $833
2018-03-31 $889
2017-12-31 $912
2017-09-30 $887
2017-06-30 $892
2017-03-31 $881
2016-12-31 $842
2016-09-30 $842
2016-06-30 $814
2016-03-31 $815
2015-12-31 $797
2015-09-30 $779
2015-06-30 $777
2015-03-31 $1,254
2014-12-31
2014-09-30
2014-06-30
2014-03-31
2013-12-31
2013-09-30
2013-06-30
2013-03-31
2012-12-31
2012-09-30
2012-06-30
2012-03-31
2011-12-31
2011-09-30
2011-06-30
2011-03-31
2010-12-31
2010-09-30
2010-06-30
2010-03-31
2009-12-31
2009-09-30
2009-06-30
2009-03-31
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $12.329B $3.350B
Dr. Reddy's Laboratories Ltd. is an integrated global pharmaceutical company engaged in providing affordable and innovative medicines since 1984. The company markets its products in countries like the U.S., the UK, Germany, India, Russia, Venezuela, Romania and South Africa. Dr. Reddy's operates through three segments: Global Generics comprising unbranded prescription drugs along with over-the-counter drugs. It includes the operations of the company's biologics business. Pharmaceutical Services & Active Ingredients (PSAI) comprising active pharmaceutical ingredients (API) and custom pharmaceutical services. Proprietary Products and Others involving the new chemical entities, the differentiated formulations business and a dermatology specialty business. The company has a strategic partnership with Glaxo to market selected products across emerging markets outside India.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $19.384B 6.36
BridgeBio Pharma (BBIO) United States $4.629B 0.00
Bausch Health Cos (BHC) Canada $3.358B 2.43
Amphastar Pharmaceuticals (AMPH) United States $2.294B 13.79
Supernus Pharmaceuticals (SUPN) United States $2.089B 28.44
Taysha Gene Therapies (TSHA) United States $0.490B 79.67
Personalis (PSNL) United States $0.278B 0.00
Assembly Biosciences (ASMB) United States $0.105B 0.00
Sol-Gel Technologies (SLGL) Israel $0.016B 0.00
Evoke Pharma (EVOK) United States $0.004B 0.00
Teligent (TLGT) United States $0.000B 0.00